Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > WHO says remdesivir provides no significant benefits

<< Previous

Bullboard Posts

Next >>

Comment by Oden6570on Nov 22, 2020 7:57am

227 Views

Post# 31948435

RE:RE:WHO says remdesivir provides no significant benefits

Yes not many on this board noticed due to the constant political pooping. We may be a therapeutic for those whom get serious infections. It would be nice if this research got expedited. TLD1433 has proven safe in humans, what harm could it be to try this on patients on incubators. Unfortunately for us the word expedite is not in Health Canada or Theralase Mgt vocabulary.

<< Previous

Bullboard Posts

Next >>

TELUS adds 347K customers in Q3